Pharmacokinetics of acebutolol in patients with all grades of renal failure-Reference-Cited by-同舟云学术

Pharmacokinetics of acebutolol in patients with all grades of renal failure

Published:1980 Issue:5 Volume:17 Page:339-348
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Roux Annie,Aubert P.,Guedon J.,Flouvat B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00558446.pdf

Reference36 articles.

1. Anavekar SN, Louis WJ, Morgan TO, Doyle AE, Johnston CI (1975) The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels. Clin Exp Pharmacol Physiol 2: 203?212

2. Bass OE, Nolph KD, Maher JF (1975) Dialysance and clearance measurements during clinical dialysis. A plea for standardization. J Lab Clin Med 86: 378?385

3. Bengtsson C, Johnsson G, Regardh CG (1975) Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long term treatment. Clin. Pharmacol Ther 17: 400?408

4. Bianchetti G, Graziani G, Brancaccio O, Morganti A, Leonetti G, Manfrinsega R, Gomeni R, Ponticelli C, Morselli PL (1976) Pharmacokinetics and effects of propranolol in terminal uraemic patients ant in patients undergoing regular dialysis treatment. Clin Pharmacokinet 1: 373?384

5. Bodem G, Grieser H, Eichelbaum M, Gugler R (1974) Pharmacokinetics of practolol in renal failure. Eur J Clin Pharmacol 7: 249?252

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensive treatment of end-stage renal disease patients on hemodialysis does not alter circulating ACE and ACE2 activity and angiotensin peptides;The American Journal of the Medical Sciences;2024-02

2. Impact of type of dialyzable beta-blockers on subsequent risk of mortality in patients receiving dialysis: A systematic review and meta-analysis;PLOS ONE;2022-12-30

3. β-Blocker Use and Cardiovascular Outcomes in Hemodialysis: A Systematic Review;Kidney Medicine;2022-05

4. Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup;Critical Care;2021-06-10

5. A Physiological Approach to Pharmacokinetics in Chronic Kidney Disease;The Journal of Clinical Pharmacology;2020-11